Laurion Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100,000
Closed -$20M 493
2023
Q3
$20M Hold
100,000
0.12% 149
2023
Q2
$18.5M Buy
+100,000
New +$18.5M 0.1% 164
2020
Q4
Sell
-9,600
Closed -$1.61M 679
2020
Q3
$1.61M Sell
9,600
-28,800
-75% -$4.85M 0.02% 342
2020
Q2
$6.24M Buy
+38,400
New +$6.88M 0.07% 205
2018
Q1
Sell
-22,900
Closed -$3.35M 1379
2017
Q4
$3.35M Sell
22,900
-32,900
-59% -$4.69M 0.02% 640
2017
Q3
$7.57M Buy
55,800
+32,900
+144% +$4.16M 0.03% 386
2017
Q2
$2.87M Sell
22,900
-25,200
-52% -$3.01M 0.02% 692
2017
Q1
$5.71M Sell
48,100
-120,900
-72% -$14.5M 0.04% 392
2016
Q4
$19.5M Buy
+169,000
New +$18.8M 0.19% 132

Other funds holding CME

Laurion Capital Management's CME Position: Q1 2026 in Review

Laurion Capital Management reduced its CME Group (CME) stake by 4.5% in Q1 2026, selling an estimated $645K and leaving 46,433 shares worth $13.7M. The position accounts for 0.6% of the portfolio, ranked #37.

Laurion Capital Management first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.9M in Q2 2023. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Laurion Capital Management held 46,433 shares of CME Group worth $13.7M as of Q1 2026.
  • Laurion Capital Management sold 2,171 CME Group shares in Q1 2026, an estimated $645K.
  • CME Group made up 0.6% of Laurion Capital Management's portfolio in Q1 2026, its #37 holding.
  • Laurion Capital Management first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Laurion Capital Management's CME Group position peaked at $18.9M in Q2 2023.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.